Follow-up of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesions (ASC-H)
Keywords:
Neoplasms squamous cell, Uterine cervical neoplasms, Vaginal smears, Biopsy, Follow-up studiesAbstract
CONTEXT AND OBJECTIVE: The concept that the presence of atypical squamous cells cannot exclude high-grade squamous intraepithelial lesions (ASC-H) was introduced in the 2001 Bethesda System of cervical cytology classification. This nomenclature defines cervical cancer precursor lesions. The objective of this study was to investigate the colpocytological-histological results from a three-year follow-up conducted on a cohort of women with reports of ASC-H who were attended during 2005-2006 at clinics of the Southern Metropolitan Healthcare Service of Santiago, Chile. DESIGN AND SETTING: Prospective cohort study at primary healthcare clinics in Santiago, Chile. METHODS: Colpocytological-histological follow-up was conducted over a three-year period on 92 women with cytological reports of ASC-H who were attended at primary healthcare clinics during 2005-2006. RESULTS: At the end of the follow-up period, high-grade lesions were evaluated and the following outcomes were observed: seven women presented invasive cancer (7.6%), 49 presented high-grade lesions (53.3%), 26 presented low-grade lesions (28.2%) and 10 presented normal results (10.9%). The “Conditional Probabilities Tree Diagram” was used to show the results from tests and the times of lesion detection. It demonstrated that, after a first report of ASC-H, clinical management needed to be interventionist. CONCLUSION: The follow-up on our cohort of women showed that the majority of uncertain ASC-H diagnoses (82.6%) had abnormal colposcopic results and that during the follow-up using ASC-H smears, two out of every three women developed high-grade lesions.
Downloads
References
Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114-9.
Sherman ME, Solomon D, Schiffman M, ASCUS LSIL Triage Study Group. Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS/LSIL Triage Study. Am J Clin Pathol. 2001;116(3):386-94.
Srodon M, Parry Dilworth H, Ronnett BM. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: diagnostic performance, human papillomavirus testing, and follow- up results. Cancer. 2006;108(1):32-8.
Sherman ME, Castle PE, Solomon D. Cervical cytology of atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): characteristics and histologic outcomes. Cancer. 2006;108(5):298-305.
Patton AL, Duncan L, Bloom L, Phaneuf G, Zafar N. Atypical squamous cells, cannot exclude a high-grade intraepithelial lesion and its clinical significance in postmenopausal, pregnant, postpartum, and contraceptive-use patients. Cancer. 2008;114(6):481-8.
Bonvicino A, Huitron S, Fadare O. Papanicolaou test interpretations of “atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion’’: an investigation of requisite duration and number of colposcopic procedures to a definitive diagnosis of high- grade dysplasia in routine practice. Cancer. 2007;111(6):477-81.
Cytryn A, Russomano FB, Camargo MJ, et al. Prevalence of cervical intraepithelial neoplasia grades II/III and cervical cancer in patients with cytological diagnosis of atypical squamous cells when high- grade intraepithelial lesions (ASC-H) cannot be ruled out. Sao Paulo Med J. 2009;127(5):283-7.
Gobierno de Chile. Ministerio de Salud. División Prevención Y Control de Enfermedades. Depto Enfermedades no Transmisibles. Terminología para el informe citológico de muestras cervicales (PAP). Available from: http://www.redsalud.gov.cl/archivos/cancer/Informa_cambio_Nomenclatura_2005.pdf. Accessed in 2013 (Apr 16).
Base de datos Cito-Expert: Consolidado nacional citologías e histologías [Acceso en línea, restringido a servicios de salud pertenecientes a la red pública de atención del Minsal, Chile]. Chile: Laboratorio Nacional de Referencia. Ministerio de Salud Chile.
Gaete JL, Fuhrer K, Soto R, Rojas JL. Pap atípico escamoso: ¿un falso negativo? [Squamous atypical vaginal smears: a false negative?] Clin Cienc. 2003;1(6):13-24.
Yazigi I R, Rodríguez A T, Contreras M L, Alcaíno M MI. El significado clínico de dos papanicolaou atípicos consecutivos [Clinical significance of 2 consecutive atypical Pap smears]. Rev Chil Obstet Ginecol. 2005;70(6):386-90.
Davey DD, Neal MH, Wilbur DC, et al. Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2004;128(11):1224-9.
Gupta S, Sodhani P, Chachra KL, Singh V, Sehgal A. Outcome of ‘‘Atypical squamous cells’’ in a cervical cytology screening program: implications for follow up in resource limited settings. Diagn Cytopathol. 2007;35(11):677-80.
Okonda S, Wright C, Michelow P. The status of cervical cytology in Swaziland, Southern Africa: a descriptive study. Cytojournal. 2009;6:14.
Yamamoto LSU, Pereira SMM, Etlinger D, et al. Frequência de diagnóstico de lesões do colo uterino por faixa etária em mulheres atendidas no Programa de Rastreamento Viva Mulher no período de 2004 a 2008 [Review on the occurrence of uterine cervix lesions according to age group among women enrolled in the Viva Mulher – Prevention Program during the period from 2004 to 2008]. Rev Inst Adolfo Lutz. 2009;68(1):126-32.
Saad RS, Dabbs DJ, Kordunsky L, et al. Clinical significance of cytologic diagnosis of atypical squamous cells, cannot exclude high grade, in perimenopausal and postmenopausal women. Am J Clin Pathol. 2006;126(3):381-8.
Barreth D, Schepansky A, Capstick V, et al. Atypical squamous cells- cannot exclude high-grade squamous intraepithelial lesion (ASC-H): a result not to be ignored. J Obstet Gynaecol Can. 2006;28(12):1095-8.
Louro AP, Roberson J, Eltoum I, Chhieng DC. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion. A follow- up study of conventional and liquid-based preparations in a high-risk population. Am J Clin Pathol. 2003;120(3):392-7.
Selvaggi SM. Reporting of atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) on cervical samples: is it significant? Diagn Cytopathol. 2003;29(1):38-41.
Elsheikh TM, Kirkpatrick JL, Wu HH. The significance of ‘‘low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion’’ as a distinct squamous abnormality category in Papanicolaou tests. Cancer. 2006;108(5):277-81.
Alsharif M, Kjeldahl K, Curran C, et al. Clinical significance of the diagnosis of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion. Cancer. 2009;117(2):92-100.
Duncan LD, Jacob SV. Atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion: the practice experience of a hospital-based reference laboratory with this new Bethesda system diagnostic category. Diagn Cytopathol. 2005;32(4):243-6.
Rekhi B, Ajit D, Joseph SK, Gawas S, Deodhar KK. Evaluation of atypical squamous cells on conventional cytology smears: An experience from a screening program practiced in limited resource setting. Cytojournal. 2010;7:15.
Giorgi Rossi P, Chini F, Bisanzi S, et al. Distribution of high and low risk HPV types by cytological status: a population based study from Italy. Infect Agent Cancer. 2011;(6):2.
Wright TC Jr, Cox JT, Massad LS, et al. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287(16):2120-9.
Ministerio de Salud. Guía clínica cancer cervicouterino 2. 1st ed. Santiago: Minsal; 2005. Available from: http://www.redsalud.gov.cl/archivos/guiasges/CancerCervicouterino.pdf. Accessed in 2013 (Mar 15).
Ministerio de Salud. Guía clínica cancer cervicouterino. Revisión y Actualización Santiago: Minsal; 2010. Available from: http://www.redsalud.gov.cl/portal/url/item/720bfefe91e9d2ede04001011f010ff2.pdf. Accessed in 2013 (Mar 15).
McHale MT, Souther J, Elkas JC, Monk BJ, Harrison TA. Is atypical squamous cells that cannot exclude high-grade squamous intraepithelial lesion clinically significant? J Low Genit Tract Dis. 2007;11(2):86-9.
Mokhtar GA, Delatour NL, Assiri AH, et al. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: cytohistologic correlation study with diagnostic pitfalls. Acta Cytol. 2008;52(2):169-77.
